UK SBS PregnAnZI-2 doubleblind clinical trial pharmaceuticals
PregnAnZi-2 is a follow on from a smaller batch trial (PregnAnZi-1) which involved 829 patients. The new trial will involve ca. 12,500. This supplier provided the azithromycin and placebo blisters for the previous trial and therefore it is a requirement to use them again for this expanded trial.
Buyer
UK SHARED BUSINESS SERVICES LIMITED
Value
£36,835
Published
3 Mar 2017
Closes
3 Mar 2017
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
6 Mar 2017
Contract ends
8 May 2017
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default UK SBS PregnAnZI-2 doubleblind clinical trial pharmaceuticals
£36,835
PregnAnZi-2 is a follow on from a smaller batch trial (PregnAnZi-1) which involved 829 patients. The new trial will involve ca. 12,500. This supplier provided the azithromycin and placebo blisters for the previous trial and therefore it is a requirement to use them again for this expanded trial.
Delivery: London · United Kingdom, London, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
3 Mar 2017
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.